Where does Vanguard Seed, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vanguard Seed, Inc. ranks #21,991 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vanguard Seed, Inc. hold?

Vanguard Seed, Inc. holds 13 US utility patents granted between 2016 and 2020, spanning 5 technology areas.

What is Vanguard Seed, Inc.'s Innovation Score?

Vanguard Seed, Inc. has an Innovation Score of 30.8 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vanguard Seed, Inc.'s patent grant rate increasing or decreasing?

Vanguard Seed, Inc.'s recent grant velocity is -92% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Vanguard Seed, Inc.'s patents?

Vanguard Seed, Inc.'s patents average 23.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vanguard Seed, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Vanguard Seed, Inc.

Q: What technology areas does Vanguard Seed, Inc. focus on?

Vanguard Seed, Inc.'s top technology area is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques) with 13 patents, ranking #54 of 285 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vanguard ranks #21,991 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#21,991
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.8/100): 23.0
avg claims per patent: -92%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21991 · US Corporation #21,991 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,991/49,997
PHOTO-FINISH UroGen Pharma
CPC-NARROW A01H · 5 areas
INNOV-THIN 30.8/100
CLAIMS-DENSE 23.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -92% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: UroGen Pharma Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vanguard’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (30%) Velocity 0.0 pts (0%) Breadth 7.9 pts (26%) Claim depth 13.8 pts (45%)

Qualcomm Incorporated · highest

85
Vanguard Seed · this assignee

31
3D Lighting… · lowest

7

What this shows Vanguard's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vanguard?

Each dot is one of Vanguard’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vanguard’s own 23.0 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Vanguard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vanguard's grants concentrate

Vanguard Seed, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2020. By volume, Vanguard sits between UroGen Pharma Ltd. and Verbio Vereinigte Bioenergie AG.

Urogen Pharma

13
Urugus

13
Vadovations

13
Valor Fire Safety

13
Vault Pressure Co…

13
VCG Holdings

13
Ventra Group

13
Verbio Vereinigte…

13
Vanguard Seed ◀

13

What this shows Vanguard holds 13 patents at rank #21,983, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vanguard

By rank, the assignees closest to #21,983 in granted patent volume.

Leaders in A01H (NEW Plants OR)

Other assignees with the most granted patents in Vanguard's primary technology class.

Vanguard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Vanguard Seed, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	23.1%
2017	2	15.4%
2018	5	38.5%
2019	2	15.4%
2020	1	7.7%

Which technologies does Vanguard Seed, Inc. patent most?

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C12Y - Enzymes 2

C07K - Peptides 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vanguard Seed, Inc.'s patent record in context - here's where to go next.

Vanguard Seed, Inc.'s lead technology class is A01H (NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques), 100% of its portfolio - see every assignee active in that class. Explore A01H
Ranked #21,991 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vanguard Seed, Inc. against UroGen Pharma Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.